Brief: Agile Therapeutics Says Cash, Cash Equivalents And Marketable Securities Sufficient To Meet Operating Requirements Through 2021-End
11/01/2021 12:15
Jan 11 (Reuters) - Agile Therapeutics Inc AGRX.O :
* AGILE THERAPEUTICS INC - CASH, CASH EQUIVALENTS &
MARKETABLE
SECURITIES WILL BE SUFFICIENT TO MEET OPERATING REQUIREMENTS
THROUGH 2021-END
Source text: [ID: https://bit.ly/39iUK4h]
Further company coverage: AGRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Agile Therapeutics
See all newsBrief: Agile Therapeutics Inc. Announces Definitive Merger Agreement With Insud Pharma, S.L.
Agile Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Agile Therapeutics Announces Delisting From Nasdaq
Agile Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: Agile Therapeutics Completes Pay-Off Of Debt